We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Henry Schein
HSIC
$9.74B
| $632K | 0.01% |
10,744
-22,856
| -68% | -$1.47M |
|
1252
Stepan Co
SCL
$1.31B
| $632K | 0.01% |
5,800
-2,418
| -29% | -$265K |
|
1253
CALL
Target
TGT
$62.1B
| $630K | 0.01% |
+4,000
| New | +$549K |
|
|
1254
PUT
Target
TGT
$62.1B
| $630K | 0.01% |
+4,000
| New | +$549K |
|
1255
NETSCOUT
NTCT
$2.86B
| $629K | 0.01% |
28,828
-40,886
| -59% | -$988K |
|
|
FRGI
1256
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $629K | 0.01% |
67,124
+37,407
| +126% | +$324K |
|
|
FRG
1257
DELISTED
Franchise Group, Inc.
FRG
| $628K | 0.01% |
+24,770
| New | +$593K |
|
|
UFS
1258
DELISTED
DOMTAR CORPORATION (New)
UFS
| $628K | 0.01% |
+23,908
| New | +$605K |
|
1259
Editas Medicine
EDIT
$399M
| $625K | 0.01% |
22,279
+13,977
| +168% | +$455K |
|
1260
Merit Medical Systems
MMSI
$4.43B
| $625K | 0.01% |
14,364
-5,380
| -27% | -$243K |
|
1261
AMN Healthcare
AMN
$1.28B
| $624K | 0.01% |
+10,668
| New | +$562K |
|
1262
Strategy Inc
MSTR
$33.5B
| $624K | 0.01% |
+41,460
| New | +$561K |
|
|
STOR
1263
DELISTED
STORE Capital Corporation
STOR
| $622K | 0.01% |
22,688
-17,856
| -44% | -$454K |
|
1264
Boston Properties
BXP
$11B
| $621K | 0.01% |
7,729
-33,332
| -81% | -$2.91M |
|
1265
CALL
Blackrock
BLK
$164B
| $620K | 0.01% |
+1,100
| New | +$628K |
|
|
1266
PUT
Blackrock
BLK
$164B
| $620K | 0.01% |
+1,100
| New | +$628K |
|
1267
Immunovant
IMVT
$8.09B
| $620K | 0.01% |
+17,610
| New | +$530K |
|
1268
Innoviva
INVA
$1.58B
| $620K | 0.01% |
+59,377
| New | +$755K |
|
1269
Trustmark
TRMK
$2.73B
| $619K | 0.01% |
28,934
+6,275
| +28% | +$144K |
|
1270
Accuray
ARAY
$28.4M
| $618K | 0.01% |
257,321
+176,353
| +218% | +$411K |
|
1271
Cenovus Energy
CVE
$54.6B
| $617K | 0.01% |
158,725
+117,687
| +287% | +$540K |
|
1272
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $617K | 0.01% |
+28,161
| New | +$621K |
|
1273
The Mosaic Company
MOS
$7.09B
| $617K | 0.01% |
33,753
-308,968
| -90% | -$5.03M |
|
1274
Victory Capital Holdings
VCTR
$6.08B
| $616K | 0.01% |
36,451
+21,782
| +148% | +$387K |
|
|
FBC
1275
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $616K | 0.01% |
20,785
-20,715
| -50% | -$623K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.